Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2024 is 175.77% vs -7.47% in Jun 2024
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is 164.33% vs -29.22% in Jun 2024
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2024 is 169.08% vs -31.03% in Jun 2024
Interest
QoQ Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024
Compare Quarterly Results Of Poseida Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2024 is 175.77% vs -7.47% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 662.77% vs -91.92% in Sep 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is 164.33% vs -29.22% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 163.52% vs -145.17% in Sep 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2024 is 169.08% vs -31.03% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 160.34% vs -147.61% in Sep 2023
Quarterly - Interest
QoQ Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 4.55% vs 22.22% in Sep 2023
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023






